pillbase.ru

Lynparza

Active substance: olaparib

olaparib

Centralised EU authorisationActive

Marketing holder: AstraZeneca AB

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 4
  • Lynparza
    TABLET, FILM COATED · OLAPARIB 100 mg/1
    0310-0569
    AstraZeneca Pharmaceuticals LP
  • Lynparza
    TABLET, FILM COATED · OLAPARIB 150 mg/1
    0310-0578
    AstraZeneca Pharmaceuticals LP
  • Lynparza
    TABLET, FILM COATED · OLAPARIB 100 mg/1
    0310-0668
    AstraZeneca Pharmaceuticals LP
  • Lynparza
    TABLET, FILM COATED · OLAPARIB 150 mg/1
    0310-0679
    AstraZeneca Pharmaceuticals LP
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208d-7114-76d3-a8f4-a55171972117,01a12094-293e-70bf-a3a3-8c6cc1878354,01a1209b-8ab4-79f8-9cd8-ddb5a986ede8,01a1209d-d8eb-7c13-8e2f-c4f991448567;count=4 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/003726
Registration status
Active
ATC code
L01XK01
Sources
  • product · EMA · EMEA/H/C/003726 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/003726 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/003726 · Verified 2026-10-09